Clear Harbor Asset Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Clear Harbor Asset Management’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,889	Closed	-$93K	–	451
2021 Q3	$93K	Sell	18,889 -1,500	-7%	-$7.29K	﹤0.01%	367
2021 Q2	$108K	Hold	20,389	–	–	0.01%	349
2021 Q1	$98K	Buy	20,389 +300	+1%	+$1.57K	0.01%	326
2020 Q4	$87K	Sell	20,089 -955	-5%	-$4.09K	0.01%	295
2020 Q3	$86.7K	Buy	+21,044	New	+$81.4K	0.01%	329
2020 Q1	–	Sell	-4,920	Closed	-$18.6K	–	766
2019 Q4	$18.6K	Buy	+4,920	New	+$23.6K	﹤0.01%	533
2018 Q4	–	Sell	-12,530	Closed	-$222K	–	284
2018 Q3	$222K	Sell	12,530 -3,240	-21%	-$76.1K	0.04%	217
2018 Q2	$407K	Buy	15,770 +370	+2%	+$10.2K	0.08%	161
2018 Q1	$368K	Buy	+15,400	New	+$486K	0.07%	162

Clear Harbor Asset Management's ADMS Position: Q4 2021 in Review

Clear Harbor Asset Management sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 18,889 shares — an estimated $93K sold.

Clear Harbor Asset Management first reported a position in ADMS in Q1 2018 and held it in 9 quarters. The position peaked at $407K in Q2 2018. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

Clear Harbor Asset Management reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Clear Harbor Asset Management sold 18,889 Adamas Pharmaceuticals shares in Q4 2021, an estimated $93K.
Clear Harbor Asset Management first reported a position in Adamas Pharmaceuticals in Q1 2018 and held it in 9 quarters.
Clear Harbor Asset Management's Adamas Pharmaceuticals position peaked at $407K in Q2 2018.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Clear Harbor Asset Management's 13F filing for Q4 2021, filed 21 Jan 2022.